Clinical Trials Directory

Trials / Completed

CompletedNCT01362387

R U OK? The Acceptability and Feasibility of New Communication Technologies for Follow-up After Medical Abortion

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
999 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Purpose: This randomised trial will compare outcomes and acceptability of an alternative medical abortion follow-up protocol using standardised text messaging, on-line questionnaire, or a phone interview and a low sensitivity pregnancy test with the current standard of care which consists of either a clinic visit and ultrasound scan or a telephone call and high sensitivity pregnancy test. Hypothesis: The use of "alternative" methods to assess outcomes after early medical abortion will achieve a higher rate of follow-up than women undergoing "standard" follow-up Primary aim: To determine the follow-up rate after early medical abortion with an alternative protocol as compared to a standard follow-up protocol Secondary aims: * To assess complication rates and receipt of further treatment among women in the two study arms * To ascertain women's preferences for mode of communication regarding their post-medical abortion status * To determine provider opinions and preferences for different follow-up modalities

Conditions

Interventions

TypeNameDescription
OTHERAlternative follow-up protocolWomen (n=1000) will be allocated by chance to one of two groups: alternative follow-up using a standard text message, online or telephone questionnaire and a low sensitivity urine pregnancy test, or standard follow-up which consists of an in person visit with an ultrasound or a telephone call and high sensitivity pregnancy test.

Timeline

Start date
2011-04-01
Primary completion
2011-12-01
Completion
2011-12-01
First posted
2011-05-30
Last updated
2013-02-15

Locations

4 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01362387. Inclusion in this directory is not an endorsement.